Latest Breaking News On - Ceoof ducentis - Page 1 : comparemela.com

First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its scienceDucentis lead pre-clinical asset DS-234 is being developed for the

United statesCity ofUnited kingdomClare terlouwPrnewswire lifearcPhilip huxleyMo noonan jonathan birtMaria tennantCeoof ducentisFrank watanabeJanet morganArcutisbiotherapeutics incLifearc venturesLifearc ventureArcuti presidentChief executive